Back to Search Start Over

Data From a One-Stop-Shop Comprehensive Cancer Screening Center

Authors :
Ezra Bernstein
Shahar Lev-Ari
Shiran Shapira
Ari Leshno
Udi Sommer
Humaid Al-Shamsi
Meital Shaked
Ori Segal
Lior Galazan
Mori Hay-Levy
Miri Sror
Amira Harlap-Gat
Michael Peer
Menachem Moshkowitz
Ido Wolf
Eliezer Liberman
Gil Shenberg
Eyal Gur
Hanoch Elran
Gustavo Melinger
Jacob Mashiah
Ofer Isakov
Elad Zrifin
Nathan Gluck
Roy Dekel
Shlomi Kleinman
Galit Aviram
Arye Blachar
Ada Kessler
Orit Golan
Ravit Geva
Ofer Yossepowitch
Alfred I. Neugut
Nadir Arber
Source :
Journal of Clinical Oncology. 41:2503-2510
Publication Year :
2023
Publisher :
American Society of Clinical Oncology (ASCO), 2023.

Abstract

PURPOSE Cancer is the second leading cause of death globally. However, by implementing evidence-based prevention strategies, 30%-50% of cancers can be detected early with improved outcomes. At the integrated cancer prevention center (ICPC), we aimed to increase early detection by screening for multiple cancers during one visit. METHODS Self-referred asymptomatic individuals, age 20-80 years, were included prospectively. Clinical, laboratory, and epidemiological data were obtained by multiple specialists, and further testing was obtained based on symptoms, family history, individual risk factors, and abnormalities identified during the visit. Follow-up recommendations and diagnoses were given as appropriate. RESULTS Between January 1, 2006, and December 31, 2019, 8,618 men and 8,486 women, average age 47.11 ± 11.71 years, were screened. Of 259 cancers detected through the ICPC, 49 (19.8%) were stage 0, 113 (45.6%) stage I, 30 (12.1%) stage II, 25 (10.1%) stage III, and 31(12.5%) stage IV. Seventeen cancers were missed, six of which were within the scope of the ICPC. Compared with the Israeli registry, at the ICPC, less cancers were diagnosed at a metastatic stage for breast (none v 3.7%), lung (6.7% v 11.4%), colon (20.0% v 46.2%), prostate (5.6% v 10.5%), and cervical/uterine (none v 8.5%) cancers. When compared with the average stage of detection in the United States, detection was earlier for breast, lung, prostate, and female reproductive cancers. Patient satisfaction rate was 8.35 ± 1.85 (scale 1-10). CONCLUSION We present a proof of concept study for a one-stop-shop approach to cancer screening in a multidisciplinary outpatient clinic. We successfully detected cancers at an early stage, which has the potential to reduce morbidity and mortality as well as offer substantial cost savings. [Media: see text]

Subjects

Subjects :
Cancer Research
Oncology

Details

ISSN :
15277755 and 0732183X
Volume :
41
Database :
OpenAIRE
Journal :
Journal of Clinical Oncology
Accession number :
edsair.doi...........23bec9a8c1fdbc86b0705cb7784bff96
Full Text :
https://doi.org/10.1200/jco.22.00938